neurizon ApS: Financial statements 2024
CVR: 36889845
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
neurizon ApS (CVR 36889845) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,787 and a net result of DKK -585 compared with DKK 1,568 the year before. Equity in the 2024 report amounted to DKK 90,818. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 1,787
- Profit/Loss
- DKK -585
- Equity
- DKK 90,818
- Total Assets
- DKK 90,818
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 0 | 2 t. | -585 | 91 t. | - |
| 2023 | 0 | -1 t. | 2 t. | 93 t. | - |
| 2022 | - | 7 t. | 2 t. | 97 t. | - |
| 2021 | - | -32 t. | -32 t. | 124 t. | - |
| 2020 | 112 t. | 107 t. | 107 t. | 163 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Neurizon ApS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK 1,568.
About neurizon ApS
neurizon ApS is a Danish company of the type Anpartsselskab based in Egå, founded in 2015. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kaare Stenhøj Meier. The board consists of Jens Christian Hedemann Sørensen (chair), Kaare Stenhøj Meier, Mattias karl Johan Valdemar Rasmusson and Morten Flink. The company's owners include ITMEDICO HOLDING ApS, KYNOS ApS and Neurologic Holding ApS. In 2025, the company reported a gross profit of DKK 4,175 and a net result of DKK 1,642 compared with DKK -585 the year before. Equity in the 2025 report amounted to DKK 92,461.